GEOVAX LABS, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GEOVAX LABS, INC. stock issued during period, value, other for the quarter ending 2020-03-31 was $300.00K, a 38.78% decline year-over-year.
- GEOVAX LABS, INC. stock issued during period, value, other for the quarter ending 2019-09-30 was $700.00K, a 16.67% increase year-over-year.
- GEOVAX LABS, INC. stock issued during period, value, other for the quarter ending 2019-06-30 was $500.00K.
- GEOVAX LABS, INC. stock issued during period, value, other for the quarter ending 2019-03-31 was $490.00K, a 16.95% decline year-over-year.
- GEOVAX LABS, INC. stock issued during period, value, other for fiscal 2020 was $300.00K, a 82.25% decline from fiscal 2019.
- GEOVAX LABS, INC. stock issued during period, value, other for fiscal 2019 was $1.69M, a 42.02% increase from fiscal 2018.
- GEOVAX LABS, INC. stock issued during period, value, other for fiscal 2018 was $1.19M, a 21.43% increase from fiscal 2017.
- GEOVAX LABS, INC. stock issued during period, value, other for fiscal 2017 was $980.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2020-12-31 | $300.00K 10-K · filed 2022-03-09 | |
| 2020-03-31 | $300.00K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $1.69M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $700.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $500.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $490.00K 10-Q · filed 2020-08-10 | |
| 2018-12-31 | $1.19M 10-K · filed 2020-03-24 | |
| 2018-09-30 | $600.00K 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $590.00K 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $980.00K 10-K · filed 2019-03-26 | |
| 2015-12-31 | $2.68M 10-K · filed 2018-03-23 | |
| 2013-12-31 | $1.62M 10-K · filed 2016-03-16 | |
| 2012-12-31 | $2.00M 10-K · filed 2015-03-20 | |
| 2009-12-31 | $1.52M 10-K · filed 2012-03-30 | |
| 2008-12-31 | $406.09K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |